Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia in animals can be hereditary, congenital, or acquired, with treatments and outcomes varying widely.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Most patients with cicatricial alopecias face significant psychological and social challenges due to their hair loss.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Taller men are seen as more attractive, and hair loss negatively affects attractiveness.

Many transgender men on testosterone therapy experience hair loss.

Obese people have more and worse skin problems than those of normal weight.

Sardinians were historically short due to a mix of genetics and factors like disease and poor nutrition, but recent height increases suggest better living conditions had a bigger impact.

Where a rhesus macaque used to live can affect its chances of getting alopecia later in life, and females are more likely to be affected than males.

Balanced hormones are crucial for women's health, and can be managed with lifestyle changes or hormone therapy if needed.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Hirsutism is often caused by high male hormone levels and can be treated with lifestyle changes and medications.

PAD is common but often missed, needing lifestyle changes and medication for better outcomes.

Targeting impaired Nrf2 signaling might help treat hidradenitis suppurativa early on.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Sexually transmitted infections and HIV should be considered as possible causes of chronic diarrhea, especially in men who have sex with men.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Hair loss was most commonly due to alopecia areata, androgenetic alopecia, and telogen effluvium, with a higher number of cases in the 1990s and equal occurrence in men and women.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Male pattern baldness worsens with age and can be treated with medications like minoxidil and finasteride, but side effects and personalized care are important.

Polycystic Ovary Syndrome (PCOS) often leads to severe acne, and lifestyle changes and hormonal treatments can help manage it.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

Vitiligo patients should be routinely screened for thyroid disease and, if extensive or prolonged, also for RA, PA, and type 2 diabetes.

Scleroderma patients have lower hair miR-29a levels.